Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients - Concepedia

Concepedia

Publication | Closed Access

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients

94

Citations

21

References

2003

Year

Domenica Lorusso, Gabriella Ferrandina, Stefano Greggi, Angiolo Gadducci, Sandro Pignata, Saverio Tateo, R. Biamonte, Luigi Manzione, Giovanni Di Vagno, Francesco Ferraù,

Annals of Oncology

Phase Iii MulticenterMedicineMetronomic TherapyPharmacologyClinical TrialsGynecologyPharmacotherapyCancer TreatmentFirst-line ChemotherapyOncologyGynecology OncologyOvarian Cancer PatientsOvarian Cancer

References

	Year	Citations

Page 1

Page 1